For the quarter ended September 2024, Figs (FIGS) reported revenue of $140.21 million, down 1.5% over the same period last year. EPS came in at -$0.01, compared to $0.03 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $144.11 million, representing a surprise of -2.71%. The company delivered an EPS surprise of +50.00%, with the consensus EPS estimate being -$0.02.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and ho ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________________ to ___________________ Commission File Number: 001-40448 FIGS, Inc. (Exact Name of Registrant as Specified in its Charter) Dela ...

FIGS Releases Third Quarter 2024 Financial Results Completed State-of-the-Art Fulfillment Center Transition Announces Minority Investment in OOG, Inc., A New Online Platform for Healthcare Professionals Updates Full Year 2024 Outlook SANTA MONICA, Calif., November 7, 2024 — FIGS, Inc. (NYSE: FIGS) (the "Company"), the global leading healthcare apparel brand dedicated to improving the lives of healthcare professionals, today released its third quarter 2024 financial results and published a financial highligh ...

Thomas Barwick/DigitalVision via Getty Images FIGS (NYSE:FIGS) 2Q24 results were not spectacular, with the company posting moderate growth and improved guidance, but at the expense of lower margins. The company is spending more on product and marketing to drive the top line. My view on the company and the stock has not changed. FIGS has a good product, but its lack of cost management financed by a high gross margin makes it vulnerable to competition from below. The stock discounts a significant improvement ...

n 0 F I C S Earnings Presentation 6 D USA OFIGS US$ PFIGS 199 MOHAMED H., MD SAVANNAH H., ACNP-C DISCLAIMER Nothing contained in this presentation is, or should be construed as, a recommendation, promise or representation by FIGS, Inc. (the "Company") or any officer, director, employee, agent or advisor of the Company. This presentation does not purport to be all inclusive or to contain all of the information you may desire in connection with your investigation of the Company. Information provided in this p ...

FIGS, Inc. (NYSE:FIGS) Q2 2024 Earnings Call August 8, 2024 5:00 PM ET Company Participants Todd Maron - Investor Relations Trina Spear - Co-Founder and Chief Executive Officer Kevin Fosty - Interim Chief Financial Officer Conference Call Participants Brooke Roach - Goldman Sachs Bob Drbul - Guggenheim Dana Telsey - Telsey Group Adrienne Yih - Barclays Rakesh Patel - Raymond James Chandana Madaka - KeyBanc Matt Koranda - Roth Capital Partners Nathan Feather - Morgan Stanley John Kernan - TD Cowen Brian Nage ...

The healthcare apparel company issued another disappointing earnings report. Shares of Figs (FIGS -13.99%) were taking a dive today after the apparel company best known for scrubs for healthcare workers posted disappointing second-quarter results, including a decline in profits. As of 2:42 p.m. ET, the stock was down 12.5% on the news. Figs' challenges continue Figs, which calls itself the largest direct-to-consumer platform in healthcare apparel, said that revenue increased 4.4% to $144.2 million, which ma ...

Figs (FIGS) reported $144.23 million in revenue for the quarter ended June 2024, representing a year-over-year increase of 4.4%. EPS of $0.01 for the same period compares to $0.02 a year ago. ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________________ to ___________________ Commission File Number: 001-40448 FIGS, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware ...

FIGS Releases Second Quarter 2024 Financial Results Exceeded Q2 2024 Outlook; Announcing $50 Million Share Repurchase Authorization SANTA MONICA, Calif., August 8, 2024 — FIGS, Inc. (NYSE: FIGS) (the "Company"), the global leading healthcare apparel brand dedicated to improving the lives of healthcare professionals, today released its second quarter 2024 financial results and published a financial highlights presentation on its investor relations website at ir.wearfigs.com/financials/quarterly-results. Seco ...